Comparative study between intravesical gemcitabine  versus  bacillus Calmette– Guérin in high risk superficial bladder cancer

M. H. Ali; M. E. Elazab; T. A. Salem; N. M. Hussien; M. M. Zaza

For citations:

Ali M.H., Elazab M.E., Salem T.A., Hussien N.M., Zaza M.M. Comparative study between intravesical gemcitabine versus bacillus Calmette– Guérin in high risk superficial bladder cancer. Cancer Urology. 2025;21(1):84-91. https://doi.org/10.17650/1726-9776-2025-21-1-84-91

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy